MSG2014GroupPhoto_700x250

The 2014 Muscle Study Group Meeting took place at the Beaver Hollow Conference Center (Java Center, NY) – September

The meeting, titled “Economic Considerations in the Development of New Treatments for Neuromuscular Diseases” brought together members of the pharmaceutical industry, NIH and academic researchers.

Final Agenda

2014 MSG Meeting Final Agenda

Abstracts

Meeting abstracts were published in Muscle and Nerve 2014;50:S1 (September 2014)

Presentations

The Muscle Study Group has received approval from the authors to publish the following presentations on our website.

Transcriptome Profiling Identifies Key Differences Between Patients with Recessive or Dominant Negative Mutations in Collagen VI Related MyopathiesRussell Butterfield

Complications of Pregnancy in Myotonic DystrophyNicholas Johnson

Funding New Investigators: The Role of the CTSAs Karl Kieburtz

Targeting Mitochondrial Free Radical Production in Aging Skeletal MuscleDavid Marcinek

Outcomes: MDA-NINDS WorkshopJohn Porter

Cataloging FDA’s Flexibility in Subpart H and Orphan Drug ApprovalsFrank Sasinowski

Patient-Reported Outcomes (PROs) in Randomized Clinical Trials (RCTs)Ira Shoulson

MRI in Experimental Muscle TherapeuticsTracey Willis

Sponsors

The Muscle Study Group wishes to thank the sponsors of the 2014 annual meeting:

Sarepta-Logo

NOVARTIS

Stealth_Tagline_72dpi

Idera_Logo

Alexion_logoRGBcytologoNuFACTOR-thumb

walgreens

NIHIconcopy